BKSD yields 20000000.00% · JNJ yields 2.13%● Live data
📍 BKSD pulled ahead of the other in Year 1
Combined, BKSD + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BKSD + JNJ for your $10,000?
Blueprint Technologies, Inc., a business communication company, provides telecommunication technologies, and business telecom products and services primarily in the United States. It designs, implements, finances, and supports various communication solutions through its TELEFFICIENCY program. The company offers contact center management software products for call recording, agent evaluation, and quality assurance functionality; contact center solutions to handle various types of media telephone calls, emails, fax, SMS, Web chat, and social media; and voice over Internet protocol phone services for businesses, as well as IP telephony solutions. It also provides surveillance cameras for commercial security system needs, video conferencing equipment, and virtualized voice solutions; and data network cabling, unified communications, mobility, and security solutions. The company was formerly known as Brookside Technology Holdings Corp. and changed its name to Blueprint Technologies, Inc. in February 2011. Blueprint Technologies, Inc. was incorporated in 2005 and is based in Clearwater, Florida. BluePrint Technologies, Inc. operates as a subsidiary of General Dynamics Corporation.
Full BKSD Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.